[Funding alert] UK-based InvenireX Secures £500k in Funding

The money will be used by the company to refine the finished product and send it to outside research and development facilities for additional technical verification.

Read also - Baden-based Crosstown H2R Secures over €2 Million in Funding

Daniel Todd founded InvenireX in 2021 while pursuing a PhD in DNA and nanotechnology at the University of Newcastle. With the help of programmable DNA, or "nanites," and artificial intelligence, the company has created a platform that enables scientists to quickly test raw materials for biomarkers at minuscule concentrations without the need for pre-processing.

It may find extensive use in personalized treatment, environmental monitoring, and early illness diagnosis. Currently, the organization is working with commercial partners on two proof-of-concept projects related to cancer detection and agriculture.

Read also - Munich-based VC Alpine Space Ventures Secures €10 Million in Funding

About InvenireX

To enable their scientists to speed life sciences research, InvenireX is developing ultra-sensitive, real-time instrumentation for nucleic acid identification that is powered by the most recent object-detection neural networks.